Frontlight ResearchEarly access
Trial site
Beijing Tsinghua Changgeng Hospital
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Familial hypercholesterolaemia1 trial
- Immune thrombocytopenia (ITP)1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Phase
- Phase 23 trials
- Phase 12 trials
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- ABM Therapeutics Shanghai Company Limited1 trial
- Chinese Academy of Sciences1 trial
- Hasten Biopharmaceutical Co., Ltd.1 trial
- Peking University People's Hospital1 trial
- TransThera Sciences (Nanjing), Inc.1 trial
- and 2 more
Running trials
Not yet recruiting
Recruiting
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
Recruiting
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Active, not recruiting
A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Familial hypercholesterolaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026